Ani Pharmaceuticals (ANIP) Equity Ratio (2019 - 2023)
Ani Pharmaceuticals (ANIP) posted Equity Ratio of 0.44 for Q1 2023, little changed sequentially from 0.45 in Q4 2022, and down 4.52% YoY from 0.46 in Q1 2022.
Ani Pharmaceuticals (ANIP) Equity Ratio (2019 - 2023) Analysis & Trends
Ani Pharmaceuticals has reported Equity Ratio for 5 years, with the latest figure at 0.44 in Q1 2023.
- Quarterly Equity Ratio fell 4.52% year-over-year to 0.44 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 0.44 (down 4.52% YoY) and the FY2022 annual result came in at 0.45, down 4.2% from the prior year.
- Equity Ratio was little changed at 0.44 in Q1 2023 per ANIP's latest filing, from 0.45 in the prior quarter.
- Over five years, Equity Ratio peaked at 0.47 in Q4 2019 and troughed at 0.4 in Q2 2021.
- A 5-year average of 0.44 and a median of 0.45 in 2022 frame the typical range for Equity Ratio.
- The sharpest annual moves came in 2020 and 2022: Equity Ratio slipped 8.91% in 2020, then increased 12.21% in 2022.
- Over 5 years, Equity Ratio stood at 0.47 in 2019, then retreated by 8.91% to 0.42 in 2020, then increased by 9.57% to 0.46 in 2021, then fell by 4.2% to 0.45 in 2022, then dropped by 0.39% to 0.44 in 2023.
- According to Business Quant data, Equity Ratio over the past three periods registered 0.44, 0.45, and 0.46 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Quarter) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 0.44 |
| Dec 31, 2022 | 0.45 |
| Sep 30, 2022 | 0.46 |
| Jun 30, 2022 | 0.45 |
| Mar 31, 2022 | 0.46 |
| Dec 31, 2021 | 0.46 |
| Sep 30, 2021 | 0.41 |
| Jun 30, 2021 | 0.40 |
| Dec 31, 2020 | 0.42 |
| Dec 31, 2019 | 0.47 |